These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35647784)

  • 21. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective.
    Gupta P; Kakumanu VK; Bansal AK
    Pharm Res; 2004 Oct; 21(10):1762-9. PubMed ID: 15553220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relaxation Dynamics vs Crystallization Kinetics in the Amorphous State: The Case of Stiripentol.
    Ruiz GN; Romanini M; Barrio M; Tamarit JL; Pardo LC; Macovez R
    Mol Pharm; 2017 Nov; 14(11):3636-3643. PubMed ID: 28915351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mobility of amorphous S-flurbiprofen: a dielectric relaxation spectroscopy approach.
    Rodrigues AC; Viciosa MT; Danède F; Affouard F; Correia NT
    Mol Pharm; 2014 Jan; 11(1):112-30. PubMed ID: 24215236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
    Xie T; Taylor LS
    Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Factors Governing the Liquid and Glassy States Recrystallization of Celecoxib in Binary Mixtures with Excipients of Different Molecular Weights.
    Grzybowska K; Chmiel K; Knapik-Kowalczuk J; Grzybowski A; Jurkiewicz K; Paluch M
    Mol Pharm; 2017 Apr; 14(4):1154-1168. PubMed ID: 28241116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular indicators of surface and bulk instability of hot melt extruded amorphous solid dispersions.
    Yang Z; Nollenberger K; Albers J; Craig D; Qi S
    Pharm Res; 2015 Apr; 32(4):1210-28. PubMed ID: 25270572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The development of co-amorphous drug systems].
    Yao J; Shi NQ; Wang XL
    Yao Xue Xue Bao; 2013 May; 48(5):648-54. PubMed ID: 23888685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Devitrification of amorphous celecoxib.
    Gupta P; Bansal AK
    AAPS PharmSciTech; 2005 Sep; 6(2):E223-30. PubMed ID: 16353981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coupling between chemical reactivity and structural relaxation in pharmaceutical glasses.
    Shamblin SL; Hancock BC; Pikal MJ
    Pharm Res; 2006 Oct; 23(10):2254-68. PubMed ID: 16941232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of amorphous states prepared by melt-quenching and cryomilling polymorphs of carbamazepine.
    Guinet Y; Paccou L; Danède F; Willart JF; Derollez P; Hédoux A
    Int J Pharm; 2016 Jul; 509(1-2):305-313. PubMed ID: 27237427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Raman imaging of amorphous-amorphous phase separation in small molecule co-amorphous systems.
    Kilpeläinen T; Pajula K; Ervasti T; Uurasjärvi E; Koistinen A; Korhonen O
    Eur J Pharm Biopharm; 2020 Oct; 155():49-54. PubMed ID: 32795500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the glass-forming ability of active pharmaceutical ingredients for designing supersaturating dosage forms.
    Kawakami K; Usui T; Hattori M
    J Pharm Sci; 2012 Sep; 101(9):3239-48. PubMed ID: 22531946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular dynamics and physical stability of amorphous anti-inflammatory drug: celecoxib.
    Grzybowska K; Paluch M; Grzybowski A; Wojnarowska Z; Hawelek L; Kolodziejczyk K; Ngai KL
    J Phys Chem B; 2010 Oct; 114(40):12792-801. PubMed ID: 20849135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of celecoxib tablet by hot melt extrusion technology and application of process analysis technology to discriminate solubilization effect.
    Hwang I; Renuka V; Lee JH; Weon KY; Kang CY; Lee BJ; Park JB
    Pharm Dev Technol; 2020 Jun; 25(5):525-534. PubMed ID: 31985320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dipolar Reorientations in Amorphous Nimesulide: A TSDC and DSC Study.
    Moura Ramos JJ; Diogo HP
    Curr Drug Deliv; 2017; 14(1):91-98. PubMed ID: 27160253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of celecoxib crystallization by mesoporous silica - Molecular dynamics studies leading to the discovery of the stabilization origin.
    Kramarczyk D; Knapik-Kowalczuk J; Smolka W; Monteiro MF; Tajber L; Paluch M
    Eur J Pharm Sci; 2022 Apr; 171():106132. PubMed ID: 35077845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting the Physical Stability of Amorphous Tenapanor Hydrochloride Using Local Molecular Structure Analysis, Relaxation Time Constants, and Molecular Modeling.
    Kothari S; Vippagunta RR
    Mol Pharm; 2019 Mar; 16(3):943-951. PubMed ID: 30699296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib.
    Xie T; Taylor LS
    J Pharm Sci; 2017 Jan; 106(1):100-110. PubMed ID: 27476771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.
    Seefeldt K; Miller J; Alvarez-Núñez F; Rodríguez-Hornedo N
    J Pharm Sci; 2007 May; 96(5):1147-58. PubMed ID: 17455346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion?
    Qian F; Huang J; Zhu Q; Haddadin R; Gawel J; Garmise R; Hussain M
    Int J Pharm; 2010 Aug; 395(1-2):232-5. PubMed ID: 20562003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.